Entries Invited for 1997 Rose Kushner Writing Awards

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 1
Volume 6
Issue 1

BETHESDA, Md--The American Medical Writers Association is accepting applications for the 1997 Rose Kushner Awards for Writing Achievement in the Field of Breast Cancer. A cash award of $1,000 for the winning entry in each of five categories will be provided through a grant from Zeneca Pharmaceuticals.

BETHESDA, Md--The American Medical Writers Association is acceptingapplications for the 1997 Rose Kushner Awards for Writing Achievement inthe Field of Breast Cancer. A cash award of $1,000 for the winning entryin each of five categories will be provided through a grant from ZenecaPharmaceuticals.

The awards were established in 1990 as a memorial tribute to Rose R.Kushner, a former member of the Association and a pioneer in breast cancereducation and patient advocacy. A survivor of breast cancer for 16 years,Rose Kushner died on January 7, 1990, at the age of 60.

Award categories include published lay articles (newspapers or magazines),published scientific articles (journals), brochures and monographs, books(medical and lay audiences), and scripts for video, film, or radio (medicaland lay audi-ences). Entries must have been published or shown from March1996 through March 1997.

The competition is open to AMWA and non-AMWA members. Entries may besubmitted by persons other than the writer, but the award, presented atthe AMWA Annual Conference, goes only to the writer.

The deadline for entries is May 10, 1997. For more information, contactthe American Medical Writers Association, 9650 Rockville Pike, Bethesda,MD 20814-3998. Telephone: 301-493-0003; Fax: 301-493-6384.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight the many advantages to attending the 42nd Annual Miami Breast Cancer Conference, with some additional tidbits to round out the main event.
3 experts in this video
3 experts in this video
Related Content